Sweden· SE-20100409000039
HALAVEN 0,44 mg/ml Injektionsvätska, lösning
A medicinal product containing eribulin, registered in Sweden by Eisai GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Eribulin
- Manufacturer
- Eisai GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20100409000039
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eribulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaERHOPANAAGmed s.r.o., Ostrava
- SpainERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFGAdvanz Pharma Limited
- IcelandEribulin Advanz PharmaADVANZ PHARMA Limited
- BelgiumEribulin Advanz Pharma 0.44 mg/mlAdvanz Pharma
- NorwayEribulin Advanz PharmaAdvanz Pharma Limited
- PolandEribulin BaxterBaxter Holding B.V.
- DenmarkEribulin "Viatris"Viatris Limited
- SwitzerlandEribulin Advanz Pharma 0.44 mg/ml, InjektionslösungAdvanz Pharma Specialty Medicine Switzerland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Eribulin Accord, Eribulin Advanz Pharma
- Belgium · Eribulin Advanz Pharma, Eribulin Eg
- Bulgaria · Eribulin Ever Pharma, Sclarint
- Czechia · Erhopana, Eribulin Accord
- Germany · Eribulin Aqvida, Eribulin Beta
- Denmark · Eribulin Accord, Eribulin Ever Pharma
- Estonia · Eribulin, Eribulin Accord
- Spain · Eribulina, Eribulina Advanz Pharma
- Finland · Eribulin, Eribulin Accord
- France · Eribuline Accord, Eribuline Advanz Pharma
- United Kingdom (Northern Ireland) · Eribulin Dr. Reddy's Laboratories (Uk), Eribulin Glenmark Pharmaceuticals Europe
- Greece · Eribulin Ever Pharma
- Croatia · Eribulin, Eribulin Accord
- Hungary · Eribulin Advz, Eribulin Ever Pharma
- Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
- Iceland · Advz, Eribulin Advanz Pharma
- Italy · Eribulina Advanz Pharma, Eribulina Eg
- Liechtenstein · Eribulin Baxter, Halaven
- Lithuania · Eribulin, Eribulin Accord
- Luxembourg · Eribulin Eg
- Latvia · Eribulin, Eribulin Advz
- Malta · Eribulin Tillomed
- Netherlands · Eribulin Ever Pharma, Eribuline Hikma
- Norway · Eribulin Accord, Eribulin Advanz Pharma
- Poland · Eribulin Ever Pharma
- Portugal · Eribulina Advanz Pharma, Eribulina Cttq
- Romania · Erhopana, Eribulin Ever Pharma
- Slovenia · Eribulin Ever Pharma
- Slovakia · Eribulin Advz, Eribulin Agmed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1f28124-4e19-43dc-9b0d-3b2dbeba3f9b GET /v1/drugs/e1f28124-4e19-43dc-9b0d-3b2dbeba3f9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20100409000039",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100409000039",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/halaven-epar-product-information_sv.pdf"
}See everything about eribulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.